Literature DB >> 21340898

Assessment of Gelatinases (MMP-2 and MMP-9 by Gelatin Zymography.

M Toth1, R Fridman.   

Abstract

The invasion and metastasis of tumor cells has been shown to require proteolytic activity in order to degrade components of the extracellular matrix (ECM). The hydrolysis of the ECM appears to facilitate tumor cell migration contributing to the metastatic dissemination of malignant cells (1). A major group of proteases that has been directly associated with tumor metastasis is the matrix metalloproteinases (MMPs), a family of endopeptidases known to cleave many ECM proteins (1). The MMPs are multidomain proteases that contain a zinc atom in the active site and are produced in a latent inactive form (zymogen) (2). Acquisition of enzymatic activity requires cleavage of the inhibitory N-terminal domain (3). Thus, generation of the active form usually occurs concomitantly with a decrease in molecular mass and exposure of the active site. Once activated, all the MMPs are specifically inhibited by a group of endogenous protease inhibitors known as the tissue inhibitors of metalloproteinases (TIMPs), which bind to the active site inhibiting catalytic activity (4).

Entities:  

Year:  2001        PMID: 21340898      PMCID: PMC3845455          DOI: 10.1385/1-59259-136-1:163

Source DB:  PubMed          Journal:  Methods Mol Med        ISSN: 1543-1894


  16 in total

Review 1.  Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation.

Authors:  L A Liotta; P S Steeg; W G Stetler-Stevenson
Journal:  Cell       Date:  1991-01-25       Impact factor: 41.582

2.  Gelatinases A and B.

Authors:  G Murphy; T Crabbe
Journal:  Methods Enzymol       Date:  1995       Impact factor: 1.600

3.  Quantification of matrix metalloproteinases in tissue samples.

Authors:  J F Woessner
Journal:  Methods Enzymol       Date:  1995       Impact factor: 1.600

4.  Tissue inhibitors of matrix metalloendopeptidases.

Authors:  G Murphy; F Willenbrock
Journal:  Methods Enzymol       Date:  1995       Impact factor: 1.600

5.  H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen.

Authors:  I E Collier; S M Wilhelm; A Z Eisen; B L Marmer; G A Grant; J L Seltzer; A Kronberger; C S He; E A Bauer; G I Goldberg
Journal:  J Biol Chem       Date:  1988-05-15       Impact factor: 5.157

Review 6.  Matrix metalloproteinases: a review.

Authors:  H Birkedal-Hansen; W G Moore; M K Bodden; L J Windsor; B Birkedal-Hansen; A DeCarlo; J A Engler
Journal:  Crit Rev Oral Biol Med       Date:  1993

7.  Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates.

Authors:  C Heussen; E B Dowdle
Journal:  Anal Biochem       Date:  1980-02       Impact factor: 3.365

Review 8.  Activation mechanisms of matrix metalloproteinases.

Authors:  H Nagase
Journal:  Biol Chem       Date:  1997 Mar-Apr       Impact factor: 3.915

9.  Domain structure of human 72-kDa gelatinase/type IV collagenase. Characterization of proteolytic activity and identification of the tissue inhibitor of metalloproteinase-2 (TIMP-2) binding regions.

Authors:  R Fridman; T R Fuerst; R E Bird; M Hoyhtya; M Oelkuct; S Kraus; D Komarek; L A Liotta; M L Berman; W G Stetler-Stevenson
Journal:  J Biol Chem       Date:  1992-08-05       Impact factor: 5.157

View more
  70 in total

1.  Design, synthesis, biochemical studies, cellular characterization, and structure-based computational studies of small molecules targeting the urokinase receptor.

Authors:  Fang Wang; W Eric Knabe; Liwei Li; Inha Jo; Timmy Mani; Hartmut Roehm; Kyungsoo Oh; Jing Li; May Khanna; Samy O Meroueh
Journal:  Bioorg Med Chem       Date:  2012-06-12       Impact factor: 3.641

2.  Targeting the MMP-14/MMP-2/integrin αvβ3 axis with multispecific N-TIMP2-based antagonists for cancer therapy.

Authors:  Gal Yosef; Valeria Arkadash; Niv Papo
Journal:  J Biol Chem       Date:  2018-07-09       Impact factor: 5.157

3.  Inhibiting Matrix Metalloproteinase-2 Activation by Perturbing Protein-Protein Interactions Using a Cyclic Peptide.

Authors:  Priyanka Sarkar; Zhonghan Li; Wendan Ren; Siwen Wang; Shiqun Shao; Jianan Sun; Xiaodong Ren; Nicole G Perkins; Zhili Guo; Chia-En A Chang; Jikui Song; Min Xue
Journal:  J Med Chem       Date:  2020-06-18       Impact factor: 7.446

4.  Increased Expression of MicroRNA 551a by c-Fos Reduces Focal Adhesion Kinase Levels and Blocks Tumorigenesis.

Authors:  Lakshmi Arivazhagan; Ganesh Venkatraman; Suresh K Rayala
Journal:  Mol Cell Biol       Date:  2019-03-19       Impact factor: 4.272

5.  Probing binding and cellular activity of pyrrolidinone and piperidinone small molecules targeting the urokinase receptor.

Authors:  Timmy Mani; Degang Liu; Donghui Zhou; Liwei Li; William Eric Knabe; Fang Wang; Kyungsoo Oh; Samy O Meroueh
Journal:  ChemMedChem       Date:  2013-10-02       Impact factor: 3.466

6.  Maspin reprograms the gene expression profile of prostate carcinoma cells for differentiation.

Authors:  M Margarida Bernardo; Yonghong Meng; Jaron Lockett; Gregory Dyson; Alan Dombkowski; Alexander Kaplun; Xiaohua Li; Shuping Yin; Sijana Dzinic; Mary Olive; Ivory Dean; David Krass; Kamiar Moin; R Daniel Bonfil; Michael Cher; Wael Sakr; Shijie Sheng
Journal:  Genes Cancer       Date:  2011-11

7.  A chemical biological strategy to facilitate diabetic wound healing.

Authors:  Major Gooyit; Zhihong Peng; William R Wolter; Hualiang Pi; Derong Ding; Dusan Hesek; Mijoon Lee; Bill Boggess; Matthew M Champion; Mark A Suckow; Shahriar Mobashery; Mayland Chang
Journal:  ACS Chem Biol       Date:  2013-09-26       Impact factor: 5.100

8.  Co-delivery of curcumin and doxorubicin in PEGylated liposomes favored the antineoplastic C26 murine colon carcinoma microenvironment.

Authors:  Alina Sesarman; Lucia Tefas; Bianca Sylvester; Emilia Licarete; Valentin Rauca; Lavinia Luput; Laura Patras; Sebastian Porav; Manuela Banciu; Alina Porfire
Journal:  Drug Deliv Transl Res       Date:  2019-02       Impact factor: 4.617

9.  Engineered stem cell mimics to enhance stroke recovery.

Authors:  Paul M George; Byeongtaek Oh; Ruby Dewi; Thuy Hua; Lei Cai; Alexa Levinson; Xibin Liang; Brad A Krajina; Tonya M Bliss; Sarah C Heilshorn; Gary K Steinberg
Journal:  Biomaterials       Date:  2018-06-14       Impact factor: 12.479

10.  Runx2 transcriptome of prostate cancer cells: insights into invasiveness and bone metastasis.

Authors:  Sanjeev K Baniwal; Omar Khalid; Yankel Gabet; Ruchir R Shah; Daniel J Purcell; Deepak Mav; Alice E Kohn-Gabet; Yunfan Shi; Gerhard A Coetzee; Baruch Frenkel
Journal:  Mol Cancer       Date:  2010-09-23       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.